Insider trade

CEO sold ~$1.11M of RMD shares in the open market

Traded Sep 8, 2026 · Filed Sep 10, 2026

ResMed|RMD

~$1.11M
Reported value · 4,991 sh @ $222.4385: 466K
Holds after · shares reported: +0.1%
stock since the trade · S&P 500 -0.3%, $221.05 → $221.15 on Oct 1

Why it stands out

The boss of ResMed| sold $1.11M of ResMed| shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 8, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 10, 2026

CEO$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,110,191

Shares × reported transaction price

Timing vs results

33 days after results of Aug 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $221.05 on Sep 8, 2026, 21% above its 52-week low and 22% below its high, after a 9% rise over the previous 30 trading days

52-week range $182.82 (Jun 2, 2026) to $283.28 (Oct 7, 2025), 38% of the way up, from 251 adjusted closes. 30 trading days earlier: $203.08 on Jul 27, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+3.1%	-0.3%	+3.4%

Past results only. Not a forecast.

Source receipt

Record ID: 0000943819-26-000052
Filed / recorded: Sep 10, 2026, 2:40 PM UTC
Added to OQRO: Oct 2, 2026, 12:28 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: RESMED INC
Issuer CIK: 943819
Ticker: RMD
Reporting person: Michael J. Farrell
Relationship: Director, Officer
Officer title: Chairman and CEO
Security: ResMed Common Stock
Table: Non-derivative (Table I)
Transaction date: Sep 8, 2026
Transaction code: S
Shares / units: 4,991
Price per share: $222.4385
Acquired / disposed: Disposed (D)
Shares owned after: 466,256
Ownership form: Direct
Amendment: No

Footnotes from the filing

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.
This transaction was executed in multiple trades at prices ranging from $220.680 - $225.390. The price reported above reflects the weighted average sale price.

Around the same time

4d ago

6,461Shares

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

4d ago

3,230Shares

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record

4d ago

14KShares

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record